Prospective Registry of Acute Coronary Syndromes in Ferrara
ARYOSTO
Acute coRonary sYndrOmes proSpective regisTry Of Ferrara
1 other identifier
observational
10,000
1 country
1
Brief Summary
The ARYOSTO has been designed to describe the clinical epidemiology and the current management of acute coronary syndromes (ACS) in the area of Ferrara. Especially, the Authors will evaluate the medical and interventional management of ACS patients admitted to hospitals in the area of Ferrara and receiving coronary artery angiography and percutaneous coronary intervention (PCI) in the hub center of Ferrara (Azienda Ospedaliera Universitaria di Ferrara, Cona (FE), Italy)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2014
CompletedFirst Submitted
Initial submission to the registry
April 30, 2015
CompletedFirst Posted
Study publicly available on registry
May 8, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 30, 2032
November 14, 2023
November 1, 2023
14.5 years
April 30, 2015
November 12, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
1-year combined primary endpoint
1-year occurence of cardiac death, myocardial infarction, cerebrovascular accident
1 year
Secondary Outcomes (7)
2-year combined endpoint
2 years
3-year combined endpoint
3 years
5-year combined endpoint
5 years
annual occurrence of single components of primary endpoint
1, 2, 3, 4, 5 years
primary safety outcome
1 year
- +2 more secondary outcomes
Other Outcomes (1)
emergency room admittance
1, 2, 3, 4, 5 years
Study Arms (1)
ACS patients
prospective collection of data and follow-up
Interventions
prospective collection of data and follow-up of all patients admitted to hospital for ACS
Eligibility Criteria
patients admitted to hospital with diagnosis of acute coronary syndromes according current European guidelines
You may qualify if:
- age \>18 years
- hospital admission for acute coronary syndromes
- resident in the Ferrara area
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital of Ferrara
Cona, Ferrara, 44124, Italy
Related Publications (2)
Cimaglia P, Fortini F, Vieceli Dalla Sega F, Cardelli LS, Massafra RF, Morelli C, Trichilo M, Ferrari R, Rizzo P, Campo G. Relationship between PCSK9 and endothelial function in patients with acute myocardial infarction. Nutr Metab Cardiovasc Dis. 2022 Sep;32(9):2105-2111. doi: 10.1016/j.numecd.2022.06.020. Epub 2022 Jul 2.
PMID: 35915019DERIVEDPavasini R, Fabbri G, Marchini F, Bianchi N, Deserio MA, Sanguettoli F, Verardi FM, Segala D, Pompei G, Tonet E, Serenelli M, Caglioni S, Guardigli G, Campo G, Cultrera R. Procalcitonin Predicts Bacterial Infection, but Not Long-Term Occurrence of Adverse Events in Patients with Acute Coronary Syndrome. J Clin Med. 2022 Jan 22;11(3):554. doi: 10.3390/jcm11030554.
PMID: 35160005DERIVED
Biospecimen
whole blood, plasma, serum
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 5 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor and Interventional Cardiologist
Study Record Dates
First Submitted
April 30, 2015
First Posted
May 8, 2015
Study Start
June 1, 2014
Primary Completion (Estimated)
November 30, 2028
Study Completion (Estimated)
November 30, 2032
Last Updated
November 14, 2023
Record last verified: 2023-11